(BAS) BASF SE - Ratings and Ratios
Chemicals, Materials, Industrial, Surface, Agricultural
Dividends
| Dividend Yield | 5.03% |
| Yield on Cost 5y | 5.07% |
| Yield CAGR 5y | 0.75% |
| Payout Consistency | 94.3% |
| Payout Ratio | 81.2% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 24.1% |
| Value at Risk 5%th | 38.0% |
| Relative Tail Risk | -4.11% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.24 |
| Alpha | 1.43 |
| CAGR/Max DD | 0.22 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.605 |
| Beta | 0.320 |
| Beta Downside | 0.398 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.19% |
| Mean DD | 11.05% |
| Median DD | 11.43% |
Description: BAS BASF SE September 29, 2025
BASF SE (XETRA:BAS) is a global chemicals producer organized into six operating segments: Chemicals (petrochemicals and intermediates); Materials (advanced polymers, isocyanates, polyamides and inorganic basics); Industrial Solutions (polymer dispersions, resins, additives, electronic materials, antioxidants for automotive, coatings, construction, paper and energy markets); Surface Technologies (catalysts, battery materials, automotive OEM and refinish coatings, metal-service solutions); Nutrition & Care (ingredients for food, feed, pharma, cosmetics, detergents and FMCG); and Agricultural Solutions (seeds, traits, crop-protection chemicals and digital farming tools). The company also generates ancillary revenue from engineering services, equipment leasing and commodity trading.
Key recent metrics suggest a mixed performance landscape: FY 2023 reported adjusted EBITDA of €7.6 billion (≈10.5 % margin), while capex remained high at €5.5 billion as BASF invests in green-hydrogen projects and specialty-chemical capacity expansions. The segment most sensitive to macro-fuel price swings is Chemicals, which tracks European petrochemical feedstock spreads; by contrast, Nutrition & Care and Agricultural Solutions have shown relative resilience due to longer-term demand growth in health-conscious consumer products and sustainable agriculture. A primary sector driver is the ongoing shift toward higher-margin specialty chemicals and circular-economy solutions, which BASF aims to capture through its “Chemistry for a Sustainable Future” roadmap.
For a deeper dive into BASF’s valuation levers and scenario-based risk assessment, the ValueRay platform provides a structured framework that can help you test the robustness of your investment thesis.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (388.0m TTM) > 0 and > 6% of Revenue (6% = 3.89b TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA -2.68pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 21.18% (prev 21.20%; Δ -0.02pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 6.11b > Net Income 388.0m (YES >=105%, WARN >=100%) |
| Net Debt (21.34b) to EBITDA (7.24b) ratio: 2.95 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.75 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (892.5m) change vs 12m ago -0.00% (target <= -2.0% for YES) |
| Gross Margin 26.21% (prev 25.21%; Δ 1.01pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 80.90% (prev 79.17%; Δ 1.73pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.28 (EBITDA TTM 7.24b / Interest Expense TTM 1.16b) >= 6 (WARN >= 3) |
Altman Z'' 3.32
| (A) 0.18 = (Total Current Assets 31.90b - Total Current Liabilities 18.18b) / Total Assets 77.67b |
| (B) 0.38 = Retained Earnings (Balance) 29.75b / Total Assets 77.67b |
| (C) 0.03 = EBIT TTM 2.64b / Avg Total Assets 80.06b |
| (D) 0.66 = Book Value of Equity 29.22b / Total Liabilities 44.16b |
| Total Rating: 3.32 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 41.13
| 1. Piotroski 5.50pt |
| 2. FCF Yield 0.77% |
| 3. FCF Margin 0.72% |
| 4. Debt/Equity 0.74 |
| 5. Debt/Ebitda 2.95 |
| 6. ROIC - WACC (= -3.07)% |
| 7. RoE 1.12% |
| 8. Rev. Trend -79.95% |
| 9. EPS Trend -14.90% |
What is the price of BAS shares?
Over the past week, the price has changed by +0.92%, over one month by +4.22%, over three months by -0.38% and over the past year by +8.97%.
Is BAS a buy, sell or hold?
What are the forecasts/targets for the BAS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 48 | 7.4% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 46.5 | 4% |
BAS Fundamental Data Overview November 26, 2025
Market Cap EUR = 39.57b (39.57b EUR * 1.0 EUR.EUR)
P/E Trailing = 130.3824
P/E Forward = 21.5517
P/S = 0.6153
P/B = 1.193
P/EG = 1.3163
Beta = 0.924
Revenue TTM = 64.77b EUR
EBIT TTM = 2.64b EUR
EBITDA TTM = 7.24b EUR
Long Term Debt = 18.96b EUR (from longTermDebt, last quarter)
Short Term Debt = 4.89b EUR (from shortTermDebt, last quarter)
Debt = 23.85b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 21.34b EUR (from netDebt column, last quarter)
Enterprise Value = 60.90b EUR (39.57b + Debt 23.85b - CCE 2.52b)
Interest Coverage Ratio = 2.28 (Ebit TTM 2.64b / Interest Expense TTM 1.16b)
FCF Yield = 0.77% (FCF TTM 468.0m / Enterprise Value 60.90b)
FCF Margin = 0.72% (FCF TTM 468.0m / Revenue TTM 64.77b)
Net Margin = 0.60% (Net Income TTM 388.0m / Revenue TTM 64.77b)
Gross Margin = 26.21% ((Revenue TTM 64.77b - Cost of Revenue TTM 47.79b) / Revenue TTM)
Gross Margin QoQ = 26.50% (prev 27.89%)
Tobins Q-Ratio = 0.78 (Enterprise Value 60.90b / Total Assets 77.67b)
Interest Expense / Debt = 1.08% (Interest Expense 257.0m / Debt 23.85b)
Taxrate = 66.14% (209.0m / 316.0m)
NOPAT = 894.3m (EBIT 2.64b * (1 - 66.14%))
Current Ratio = 1.75 (Total Current Assets 31.90b / Total Current Liabilities 18.18b)
Debt / Equity = 0.74 (Debt 23.85b / totalStockholderEquity, last quarter 32.36b)
Debt / EBITDA = 2.95 (Net Debt 21.34b / EBITDA 7.24b)
Debt / FCF = 45.59 (Net Debt 21.34b / FCF TTM 468.0m)
Total Stockholder Equity = 34.69b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.50% (Net Income 388.0m / Total Assets 77.67b)
RoE = 1.12% (Net Income TTM 388.0m / Total Stockholder Equity 34.69b)
RoCE = 4.92% (EBIT 2.64b / Capital Employed (Equity 34.69b + L.T.Debt 18.96b))
RoIC = 1.55% (NOPAT 894.3m / Invested Capital 57.51b)
WACC = 4.62% (E(39.57b)/V(63.42b) * Re(7.19%) + D(23.85b)/V(63.42b) * Rd(1.08%) * (1-Tc(0.66)))
Discount Rate = 7.19% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.01%
[DCF Debug] Terminal Value 76.33% ; FCFE base≈1.36b ; Y1≈1.20b ; Y5≈996.4m
Fair Price DCF = 20.26 (DCF Value 18.08b / Shares Outstanding 892.5m; 5y FCF grow -14.37% → 3.0% )
EPS Correlation: -14.90 | EPS CAGR: -19.45% | SUE: 0.21 | # QB: 0
Revenue Correlation: -79.95 | Revenue CAGR: -5.72% | SUE: -0.03 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.10 | Chg30d=-0.075 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=2.79 | Chg30d=-0.117 | Revisions Net=-8 | Growth EPS=+3.6% | Growth Revenue=+1.8%